{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:10:23Z","timestamp":1793653823123,"version":"4.5.1"},"reference-count":187,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100017655","name":"Incyte Corporation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017655","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s40257-021-00631-6","type":"journal-article","created":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T11:44:33Z","timestamp":1632397473000},"page":"757-774","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":243,"title":["Psychosocial Effects of Vitiligo: A Systematic Literature Review"],"prefix":"10.1007","volume":"22","author":[{"given":"Khaled","family":"Ezzedine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Eleftheriadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Bibeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona I.","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sturm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit G.","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,23]]},"reference":[{"issue":"1","key":"631_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1600-0749.2006.00355.x","volume":"20","author":"A Taieb","year":"2007","unstructured":"Taieb A, Picardo M. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 2007;20(1):27\u201335.","journal-title":"Pigment Cell Res"},{"issue":"5","key":"631_CR2","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.jaad.2015.07.039","volume":"73","author":"K Ezzedine","year":"2015","unstructured":"Ezzedine K, Sheth V, Rodrigues M, Eleftheriadou V, Harris JE, Hamzavi IH, et al. Vitiligo is not a cosmetic disease. J Am Acad Dermatol. 2015;73(5):883\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"9988","key":"631_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","volume":"386","author":"K Ezzedine","year":"2015","unstructured":"Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet. 2015;386(9988):74\u201384.","journal-title":"Lancet"},{"issue":"1","key":"631_CR4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1365-2133.2009.09091.x","volume":"161","author":"MA Radtke","year":"2009","unstructured":"Radtke MA, Schafer I, Gajur A, Langenbruch A, Augustin M. Willingness-to-pay and quality of life in patients with vitiligo. Br J Dermatol. 2009;161(1):134\u20139.","journal-title":"Br J Dermatol"},{"issue":"7","key":"631_CR5","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/j.1365-2230.2009.03765.x","volume":"35","author":"N Talsania","year":"2010","unstructured":"Talsania N, Lamb B, Bewley A. Vitiligo is more than skin deep: a survey of members of the Vitiligo Society. Clin Exp Dermatol. 2010;35(7):736\u20139.","journal-title":"Clin Exp Dermatol"},{"issue":"10","key":"631_CR6","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/j.1365-4632.2011.05377.x","volume":"51","author":"C Kruger","year":"2012","unstructured":"Kruger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children\/adolescents and adults. Int J Dermatol. 2012;51(10):1206\u201312.","journal-title":"Int J Dermatol"},{"issue":"6","key":"631_CR7","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1111\/bjd.15933","volume":"177","author":"B Morrison","year":"2017","unstructured":"Morrison B, Burden-Teh E, Batchelor JM, Mead E, Grindlay D, Ratib S. Quality of life in people with vitiligo: a systematic review and meta-analysis. Br J Dermatol. 2017;177(6):e338\u20139.","journal-title":"Br J Dermatol"},{"issue":"3","key":"631_CR8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.clindermatol.2017.01.001","volume":"35","author":"F Cupertino","year":"2017","unstructured":"Cupertino F, Niemeyer-Corbellini JP, Ramos ESM. Psychosomatic aspects of vitiligo. Clin Dermatol. 2017;35(3):292\u20137.","journal-title":"Clin Dermatol"},{"issue":"6","key":"631_CR9","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1111\/bjd.15936","volume":"177","author":"Y Yang","year":"2017","unstructured":"Yang Y, Zapata L, Rodgers C, Hernandez K, Iyer M, Jia G, et al. Quality of life in patients with vitiligo using the Short Form-36. Br J Dermatol. 2017;177(6):1764\u20136.","journal-title":"Br J Dermatol"},{"issue":"3","key":"631_CR10","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/bjd.15199","volume":"177","author":"YC Lai","year":"2017","unstructured":"Lai YC, Yew YW, Kennedy C, Schwartz RA. Vitiligo and depression: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2017;177(3):708\u201318.","journal-title":"Br J Dermatol"},{"issue":"4","key":"631_CR11","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/bjd.16049","volume":"178","author":"O Osinubi","year":"2018","unstructured":"Osinubi O, Grainge MJ, Hong L, Ahmed A, Batchelor JM, Grindlay D, et al. The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta-analysis. Br J Dermatol. 2018;178(4):863\u201378.","journal-title":"Br J Dermatol"},{"issue":"8","key":"631_CR12","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1111\/jdv.14739","volume":"32","author":"G Wang","year":"2018","unstructured":"Wang G, Qiu D, Yang H, Liu W. The prevalence and odds of depression in patients with vitiligo: a meta-analysis. J Eur Acad Dermatol Venereol. 2018;32(8):1343\u201351.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"631_CR13","first-page":"745","volume":"37","author":"EL Anaba","year":"2020","unstructured":"Anaba EL, Oaku RI. Prospective cross-sectional study of quality of life of vitiligo patients using a vitiligo specific quality of life instrument. West Afr J Med. 2020;37(7):745\u20139.","journal-title":"West Afr J Med"},{"issue":"3","key":"631_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4103\/TJD.TJD_14_19","volume":"13","author":"A Temel","year":"2019","unstructured":"Temel A, Bozkurt S, Senol Y, Alpsoy E. Internalized stigma in patients with acne vulgaris, vitiligo, and alopecia areata. Turk J Dermatol. 2019;13(3):109\u201316.","journal-title":"Turk J Dermatol."},{"issue":"1","key":"631_CR15","doi-asserted-by":"publisher","first-page":"e0227909","DOI":"10.1371\/journal.pone.0227909","volume":"15","author":"SW Henning","year":"2020","unstructured":"Henning SW, Jaishankar D, Barse LW, Dellacecca ER, Lancki N, Webb K, et al. The relationship between stress and vitiligo: evaluating perceived stress and electronic medical record data. PLoS ONE. 2020;15(1):e0227909.","journal-title":"PLoS ONE"},{"issue":"1","key":"631_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/phpp.12495","volume":"36","author":"B Liu","year":"2020","unstructured":"Liu B, Sun Y, Song J, Wu Z. Home vs hospital narrowband UVB treatment by a hand-held unit for new-onset vitiligo: a pilot randomized controlled study. Photodermatol Photoimmunol Photomed. 2020;36(1):14\u201320.","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"2","key":"631_CR17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.5455\/msm.2020.32.108-111","volume":"32","author":"MA Alharbi","year":"2020","unstructured":"Alharbi MA. Identifying patients at higher risk of depression among patients with vitiligo at outpatient setting. Mater Sociomed. 2020;32(2):108\u201311.","journal-title":"Mater Sociomed."},{"issue":"4","key":"631_CR18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.47276\/lr.91.4.343","volume":"91","author":"K Udaya Kiran","year":"2020","unstructured":"Udaya Kiran K, Potharaju AR, Vellala M, Narasimha RP. Cosmetic camouflage of visible skin lesions enhances life quality indices in leprosy as in vitiligo patients: an effective stigma reduction strategy. Lepr Rev. 2020;91(4):343\u201352.","journal-title":"Lepr Rev"},{"issue":"3","key":"631_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4103\/JEWD.JEWD_32_20","volume":"17","author":"S Ibrahim","year":"2020","unstructured":"Ibrahim S, El Mofty M, Mostafa W, Esmat S, Samir N, El-Samanoudy S, et al. Monobenzyl ether of hydroquinone 20 and 40% cream in depigmentation of patients with vitiligo: a randomized controlled trial. J Egypt Womens Dermatol Soc. 2020;17(3):130\u20137.","journal-title":"J Egypt Womens Dermatol Soc."},{"issue":"1","key":"631_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s41687-020-0186-2","volume":"4","author":"G Andrade","year":"2020","unstructured":"Andrade G, Rangu S, Provini L, Putterman E, Gauthier A, Castelo-Soccio L. Childhood vitiligo impacts emotional health of parents: a prospective, cross-sectional study of quality of life for primary caregivers. J Patient Rep Outcomes. 2020;4(1):20.","journal-title":"J Patient Rep Outcomes."},{"issue":"3","key":"631_CR21","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/jdv.16927","volume":"35","author":"VS Narayan","year":"2021","unstructured":"Narayan VS, Uitentuis SE, Luiten RM, Bekkenk MW, Wolkerstorfer A. Patients\u2019 perspective on current treatments and demand for novel treatments in vitiligo. J Eur Acad Dermatol Venereol. 2021;35(3):744\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"631_CR22","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/jdv.15987","volume":"34","author":"G Dabas","year":"2020","unstructured":"Dabas G, Vinay K, Parsad D, Kumar A, Kumaran MS. Psychological disturbances in patients with pigmentary disorders: a cross-sectional study. J Eur Acad Dermatol Venereol. 2020;34(2):392\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"631_CR23","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/1346-8138.15290","volume":"47","author":"CY Chen","year":"2020","unstructured":"Chen CY, Wang WM, Chung CH, Tsao CH, Chien WC, Hung CT. Increased risk of psychiatric disorders in adult patients with vitiligo: a nationwide, population-based cohort study in Taiwan. J Dermatol. 2020;47(5):470\u20135.","journal-title":"J Dermatol"},{"issue":"7","key":"631_CR24","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1111\/jocd.13807","volume":"20","author":"S Savas Erdogan","year":"2021","unstructured":"Savas Erdogan S, Falay Gur T, Dogan B. Anxiety and depression in pediatric patients with vitiligo and alopecia areata and their parents: a cross-sectional controlled study. J Cosmet Dermatol. 2021;20(7):2232\u20139.","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"631_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/jocd.13459","volume":"20","author":"D Bassiouny","year":"2021","unstructured":"Bassiouny D, Hegazy R, Esmat S, Gawdat HI, Ahmed Ezzat M, Tawfik HA, et al. Cosmetic camouflage as an adjuvant to vitiligo therapies: effect on quality of life. J Cosmet Dermatol. 2021;20(1):159\u201365.","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"631_CR26","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jaad.2019.11.037","volume":"83","author":"A Tan","year":"2020","unstructured":"Tan A, Schuster LM, Robbins MA, Holavanahalli R, Pandya AG. Evaluation of the psychosocial impact of a Social Interaction Skills Training (SIST) workshop for patients with vitiligo: a pilot study. J Am Acad Dermatol. 2020;83(2):645\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"631_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.09.088","author":"JM Bae","year":"2020","unstructured":"Bae JM, Kim JE, Lee RW, Ju HJ, Han JH, Lee JH, et al. Beyond the quality of life: a call for patients\u2019 own willingness to pay in chronic skin disease to assess psychosocial burden: a multi-center, cross-sectional prospective survey. J Am Acad Dermatol. 2020. https:\/\/doi.org\/10.1016\/j.jaad.2020.09.088.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"631_CR28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.4103\/ijd.IJD_822_19","volume":"65","author":"N Sarma","year":"2020","unstructured":"Sarma N, Chakraborty S, Poojary S, Shashi Kumar BM, Gupta LK, Budamakuntla L, et al. A nationwide, multicentric case-control study on vitiligo (MEDEC-V) to elicit the magnitude and correlates. Indian J Dermatol. 2020;65(6):473\u201382.","journal-title":"Indian J Dermatol"},{"issue":"64","key":"631_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta24640","volume":"24","author":"JM Batchelor","year":"2020","unstructured":"Batchelor JM, Thomas KS, Akram P, Azad J, Bewley A, Chalmers JR, et al. Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT. Health Technol Assess. 2020;24(64):1\u2013128.","journal-title":"Health Technol Assess"},{"issue":"1","key":"631_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12955-020-1278-7","volume":"18","author":"N Hamidizadeh","year":"2020","unstructured":"Hamidizadeh N, Ranjbar S, Ghanizadeh A, Parvizi MM, Jafari P, Handjani F. Evaluating prevalence of depression, anxiety and hopelessness in patients with vitiligo on an Iranian population. Health Qual Life Outcomes. 2020;18(1):20.","journal-title":"Health Qual Life Outcomes"},{"key":"631_CR31","first-page":"3495165","volume":"2020","author":"AG Tsadik","year":"2020","unstructured":"Tsadik AG, Teklemedhin MZ, Mehari Atey T, Gidey MT, Desta DM. Public knowledge and attitudes towards vitiligo: a survey in Mekelle City, Northern Ethiopia. Dermatol Res Pract. 2020;2020:3495165.","journal-title":"Northern Ethiopia. Dermatol Res Pract."},{"issue":"1","key":"631_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.det.2020.08.011","volume":"39","author":"J Pun","year":"2021","unstructured":"Pun J, Randhawa A, Kumar A, Williams V. The impact of vitiligo on quality of life and psychosocial well-being in a Nepalese population. Dermatol Clin. 2021;39(1):117\u201327.","journal-title":"Dermatol Clin"},{"issue":"4","key":"631_CR33","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/ced.14511","volume":"46","author":"D Yucel","year":"2021","unstructured":"Yucel D, Sener S, Turkmen D, Altunisik N, Sarac G, Cumurcu HB. Evaluation of the Dermatological Life Quality Index, sexual dysfunction and other psychiatric diseases in patients diagnosed with vitiligo with and without genital involvement. Clin Exp Dermatol. 2021;46(4):669\u201374.","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"631_CR34","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/ced.14196","volume":"46","author":"I Ucuz","year":"2021","unstructured":"Ucuz I, Altunisik N, Sener S, Turkmen D, Kavuran NA, Marsak M, et al. Quality of life, emotion dysregulation, attention deficit and psychiatric comorbidity in children and adolescents with vitiligo. Clin Exp Dermatol. 2021;46(3):510\u20135.","journal-title":"Clin Exp Dermatol"},{"key":"631_CR35","doi-asserted-by":"publisher","first-page":"511","DOI":"10.2147\/CCID.S265349","volume":"13","author":"N Silpa-Archa","year":"2020","unstructured":"Silpa-Archa N, Pruksaeakanan C, Angkoolpakdeekul N, Chaiyabutr C, Kulthanan K, Ratta-Apha W, et al. Relationship between depression and quality of life among vitiligo patients: a self-assessment questionnaire-based study. Clin Cosmet Investig Dermatol. 2020;13:511\u201320.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"1","key":"631_CR36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/bjd.19424","volume":"184","author":"V Gupta","year":"2021","unstructured":"Gupta V, Taneja N, Sati HC, Sreenivas V, Ramam M. Evaluation of \u201cnot relevant\u201d responses on the Dermatology Life Quality Index (DLQI) and the DLQI-R scoring modification among Indian patients with vitiligo. Br J Dermatol. 2021;184(1):168\u20139.","journal-title":"Br J Dermatol"},{"issue":"3","key":"631_CR37","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.14393\/BJ-v36n3a2020-45105","volume":"36","author":"KAP Lacerda","year":"2020","unstructured":"Lacerda KAP, Silva LA, Mendonca GS, Guimar\u00e3es RA, Guilo LA. Association between quality of life and perceived stress in patients with vitiligo: case control study. Biosci J. 2020;36(3):1032\u201342.","journal-title":"Biosci J"},{"issue":"66","key":"631_CR38","first-page":"114","volume":"17","author":"B Amatya","year":"2019","unstructured":"Amatya B, Pokhrel DB. Assessment and comparison of quality of life in patients with melasma and vitiligo. Kathmandu Univ Med J (KUMJ). 2019;17(66):114\u20138.","journal-title":"Kathmandu Univ Med J (KUMJ)."},{"issue":"3","key":"631_CR39","first-page":"129","volume":"17","author":"\u00d6 Ar\u00fdcan","year":"2008","unstructured":"Ar\u00fdcan \u00d6, Ko\u00e7 K, Ersoy L. Clinical characteristics in 113 Turkish vitiligo patients. Acta Dermatovenerol Alp Pannonica Adriat. 2008;17(3):129\u201332.","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat."},{"issue":"Suppl. 1","key":"631_CR40","first-page":"S19","volume":"15","author":"G Agarwal","year":"1998","unstructured":"Agarwal G. Vitiligo: an under-estimated problem. Fam Pract. 1998;15(Suppl. 1):S19-23.","journal-title":"Fam Pract"},{"issue":"5","key":"631_CR41","first-page":"90","volume":"7","author":"D Ahmad","year":"2017","unstructured":"Ahmad D. A community based study on finding the quality of life of the patients with vitiligo. J Appl Pharm Sci. 2017;7(5):90\u20133.","journal-title":"J Appl Pharm Sci."},{"issue":"12","key":"631_CR42","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1111\/jdv.15168","volume":"32","author":"A Ahmed","year":"2018","unstructured":"Ahmed A, Steed L, Burden-Teh E, Shah R, Sanyal S, Tour S, et al. Identifying key components for a psychological intervention for people with vitiligo: a quantitative and qualitative study in the United Kingdom using web-based questionnaires of people with vitiligo and healthcare professionals. J Eur Acad Dermatol Venereol. 2018;32(12):2275\u201383.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"631_CR43","first-page":"19","volume":"19","author":"I Ahmed","year":"2007","unstructured":"Ahmed I, Ahmed S, Nasreen S. Frequency and pattern of psychiatric disorders in patients with vitiligo. J Ayub Med Coll Abbottabad. 2007;19(3):19\u201321.","journal-title":"J Ayub Med Coll Abbottabad"},{"issue":"7","key":"631_CR44","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/jdv.12216","volume":"28","author":"FO Ajose","year":"2014","unstructured":"Ajose FO, Parker RA, Merrall EL, Adewuya AO, Zachariah MP. Quantification and comparison of psychiatric distress in African patients with albinism and vitiligo: a 5-year prospective study. J Eur Acad Dermatol Venereol. 2014;28(7):925\u201332.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"631_CR45","first-page":"1414","volume":"28","author":"AA Al Robaee","year":"2007","unstructured":"Al Robaee AA. Assessment of quality of life in Saudi patients with vitiligo in a medical school in Qassim province, Saudi Arabia. Saudi Med J. 2007;28(9):1414\u20137.","journal-title":"Saudi Med J."},{"issue":"10","key":"631_CR46","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1111\/j.1365-4632.2010.04514.x","volume":"49","author":"KM AlGhamdi","year":"2010","unstructured":"AlGhamdi KM. Beliefs and perceptions of Arab vitiligo patients regarding their condition. Int J Dermatol. 2010;49(10):1141\u20135.","journal-title":"Int J Dermatol"},{"issue":"5","key":"631_CR47","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1177\/120347541201600510","volume":"16","author":"KM AlGhamdi","year":"2012","unstructured":"AlGhamdi KM, Moussa NA, Mandil A, Alkofidi M, Madani A, Aldaham N, et al. Public perceptions and attitudes toward vitiligo. J Cutan Med Surg. 2012;16(5):334\u201340.","journal-title":"J Cutan Med Surg"},{"issue":"6","key":"631_CR48","first-page":"327","volume":"11","author":"M Al-Harbi","year":"2013","unstructured":"Al-Harbi M. Prevalence of depression in vitiligo patients. Skinmed. 2013;11(6):327\u201330.","journal-title":"Skinmed."},{"issue":"1","key":"631_CR49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4103\/0974-2077.79188","volume":"4","author":"L Al-Mubarak","year":"2011","unstructured":"Al-Mubarak L, Al-Mohanna H, Al-Issa A, Jabak M, Mulekar SV. Quality of life in Saudi vitiligo patients. J Cutan Aesthet Surg. 2011;4(1):33\u20137.","journal-title":"J Cutan Aesthet Surg"},{"issue":"3","key":"631_CR50","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2310\/7750.2014.14110","volume":"19","author":"MA AlShahwan","year":"2015","unstructured":"AlShahwan MA. The prevalence of anxiety and depression in Arab dermatology patients. J Cutan Med Surg. 2015;19(3):297\u2013303.","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"631_CR51","doi-asserted-by":"publisher","first-page":"115","DOI":"10.5144\/0256-4947.2014.115","volume":"34","author":"HA Al-Shobaili","year":"2014","unstructured":"Al-Shobaili HA. Correlation of clinical efficacy and psychosocial impact on vitiligo patients by excimer laser treatment. Ann Saudi Med. 2014;34(2):115\u201321.","journal-title":"Ann Saudi Med"},{"issue":"1","key":"631_CR52","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2310\/7750.2014.14002","volume":"19","author":"HA Al-Shobaili","year":"2015","unstructured":"Al-Shobaili HA. Treatment of vitiligo patients by excimer laser improves patients\u2019 quality of life. J Cutan Med Surg. 2015;19(1):50\u20136.","journal-title":"J Cutan Med Surg"},{"issue":"3","key":"631_CR53","doi-asserted-by":"publisher","first-page":"322","DOI":"10.2340\/00015555-1940","volume":"95","author":"AA Amer","year":"2015","unstructured":"Amer AA, McHepange UO, Gao XH, Hong Y, Qi R, Wu Y, et al. Hidden victims of childhood vitiligo: impact on parents\u2019 mental health and quality of life. Acta Derm Venereol. 2015;95(3):322\u20135.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"631_CR54","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-9668.175021","volume":"7","author":"DP Asati","year":"2016","unstructured":"Asati DP, Gupta CM, Tiwari S, Kumar S, Jamra V. A hospital-based study on knowledge and attitude related to vitiligo among adults visiting a tertiary health facility of central India. J Nat Sci Biol Med. 2016;7(1):27\u201332.","journal-title":"J Nat Sci Biol Med."},{"issue":"2","key":"631_CR55","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4274\/tdd.3611","volume":"12","author":"A A\u015fk\u0131n","year":"2018","unstructured":"A\u015fk\u0131n A, \u00d6zkan A, B\u0131y\u0131kl\u0131 SE, Tosun A. Could there be a possible link between vitiligo and fibromyalgia syndrome? Turk J Dermatol. 2018;12(2):100\u20136.","journal-title":"Turk J Dermatol."},{"issue":"1","key":"631_CR56","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/bjd.15560","volume":"178","author":"JM Bae","year":"2018","unstructured":"Bae JM, Lee SC, Kim TH, Yeom SD, Shin JH, Lee WJ, et al. Factors affecting quality of life in patients with vitiligo: a nationwide study. Br J Dermatol. 2018;178(1):238\u201344.","journal-title":"Br J Dermatol"},{"issue":"4","key":"631_CR57","doi-asserted-by":"publisher","first-page":"306","DOI":"10.5350\/DAJPN2011240406","volume":"24","author":"\u00d6D Balaban","year":"2011","unstructured":"Balaban \u00d6D, Atag\u00fcn M\u0130, \u00d6zg\u00fcven HD, \u00d6zsan HH. Psychiatric morbidity in patients with vitiligo. Dusunen Adam. 2011;24(4):306\u201313.","journal-title":"Dusunen Adam."},{"issue":"5","key":"631_CR58","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/bjd.15280","volume":"176","author":"F Balieva","year":"2017","unstructured":"Balieva F, Kupfer J, Lien L, Gieler U, Finlay AY, Tomas-Aragones L, et al. The burden of common skin diseases assessed with the EQ5D: a European multicentre study in 13 countries. Br J Dermatol. 2017;176(5):1170\u20138.","journal-title":"Br J Dermatol"},{"issue":"1","key":"631_CR59","first-page":"277","volume":"28","author":"V Barisic-Drusko","year":"2004","unstructured":"Barisic-Drusko V, Rucevic I. Trigger factors in childhood psoriasis and vitiligo. Coll Antropol. 2004;28(1):277\u201385.","journal-title":"Coll Antropol"},{"issue":"8","key":"631_CR60","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1001\/jamapsychiatry.2013.1111","volume":"70","author":"ME Benros","year":"2013","unstructured":"Benros ME, Waltoft BL, Nordentoft M, Ostergaard SD, Eaton WW, Krogh J, et al. Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiat. 2013;70(8):812\u201320.","journal-title":"JAMA Psychiat"},{"issue":"3","key":"631_CR61","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1111\/jdv.15264","volume":"33","author":"B Bhatia","year":"2019","unstructured":"Bhatia B, Kechichian E, Eleftheriadou V, Castelneau JP, Seite S, Meurant JM, et al. Habits and risk perception associated with sun exposure in vitiligo patients according to their participation in a patients\u2019 organization. J Eur Acad Dermatol Venereol. 2019;33(3):e100\u20133.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"631_CR62","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2147\/CCID.S151114","volume":"11","author":"R Bidaki","year":"2018","unstructured":"Bidaki R, Majidi N, Moghadam Ahmadi A, Bakhshi H, Sadr Mohammadi R, Mostafavi SA, et al. Vitiligo and social acceptance. Clin Cosmet Investig Dermatol. 2018;11:383\u20136.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"4","key":"631_CR63","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1365-2230.2010.03965.x","volume":"36","author":"O Bilgic","year":"2011","unstructured":"Bilgic O, Bilgic A, Akis HK, Eskioglu F, Kilic EZ. Depression, anxiety and health-related quality of life in children and adolescents with vitiligo. Clin Exp Dermatol. 2011;36(4):360\u20135.","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"631_CR64","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s40257-013-0037-5","volume":"14","author":"GA Bin Saif","year":"2013","unstructured":"Bin Saif GA, Al-Balbeesi AO, Binshabaib R, Alsaad D, Kwatra SG, Alzolibani AA, et al. Quality of life in family members of vitiligo patients: a questionnaire study in Saudi Arabia. Am J Clin Dermatol. 2013;14(6):489\u201395.","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"631_CR65","first-page":"45","volume":"14","author":"K Bonotis","year":"2016","unstructured":"Bonotis K, Pantelis K, Karaoulanis S, Katsimaglis C, Papaliaga M, Zafiriou E, et al. Investigation of factors associated with health-related quality of life and psychological distress in vitiligo. J Dtsch Dermatol Ges. 2016;14(1):45\u20139.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"2","key":"631_CR66","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S1550-8579(06)80201-9","volume":"3","author":"L Borimnejad","year":"2006","unstructured":"Borimnejad L, Parsa Yekta Z, Nikbakht-Nasrabadi A, Firooz A. Quality of life with vitiligo: comparison of male and female Muslim patients in Iran. Gend Med. 2006;3(2):124\u201330.","journal-title":"Gend Med"},{"issue":"5","key":"631_CR67","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1159\/000448656","volume":"232","author":"J Catucci Boza","year":"2016","unstructured":"Catucci Boza J, Giongo N, Machado P, Horn R, Fabbrin A, Cestari T. Quality of life impairment in children and adults with vitiligo: a cross-sectional study based on dermatology-specific and disease-specific quality of life instruments. Dermatology. 2016;232(5):619\u201325.","journal-title":"Dermatology"},{"issue":"11\u201312","key":"631_CR68","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1111\/j.1365-2702.2011.03777.x","volume":"21","author":"MF Chan","year":"2012","unstructured":"Chan MF, Chua TL, Goh BK, Aw CW, Thng TG, Lee SM. Investigating factors associated with depression of vitiligo patients in Singapore. J Clin Nurs. 2012;21(11\u201312):1614\u201321.","journal-title":"J Clin Nurs"},{"issue":"Suppl. 3","key":"631_CR69","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ijn.12179","volume":"19","author":"MF Chan","year":"2013","unstructured":"Chan MF, Thng TG, Aw CW, Goh BK, Lee SM, Chua TL. Investigating factors associated with quality of life of vitiligo patients in Singapore. Int J Nurs Pract. 2013;19(Suppl. 3):3\u201310.","journal-title":"Int J Nurs Pract"},{"issue":"1","key":"631_CR70","doi-asserted-by":"publisher","first-page":"e0210581","DOI":"10.1371\/journal.pone.0210581","volume":"14","author":"D Chen","year":"2019","unstructured":"Chen D, Tuan H, Zhou EY, Liu D, Zhao Y. Quality of life of adult vitiligo patients using camouflage: a survey in a Chinese vitiligo community. PLoS ONE. 2019;14(1):e0210581.","journal-title":"PLoS ONE"},{"issue":"5","key":"631_CR71","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1468-3083.2009.03452.x","volume":"24","author":"S Choi","year":"2010","unstructured":"Choi S, Kim DY, Whang SH, Lee JH, Hann SK, Shin YJ. Quality of life and psychological adaptation of Korean adolescents with vitiligo. J Eur Acad Dermatol Venereol. 2010;24(5):524\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"631_CR72","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ajp.2016.10.011","volume":"25","author":"F Dehghani","year":"2017","unstructured":"Dehghani F, Dehghani F, Kafaie P, Taghizadeh MR. Alexithymia in different dermatologic patients. Asian J Psychiatr. 2017;25:42\u20135.","journal-title":"Asian J Psychiatr"},{"issue":"1","key":"631_CR73","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1365-4632.2012.05616.x","volume":"52","author":"SB Dertlioglu","year":"2013","unstructured":"Dertlioglu SB, Cicek D, Balci DD, Halisdemir N. Dermatology Life Quality Index scores in children with vitiligo: comparison with atopic dermatitis and healthy control subjects. Int J Dermatol. 2013;52(1):96\u2013101.","journal-title":"Int J Dermatol"},{"issue":"2","key":"631_CR74","first-page":"45","volume":"24","author":"S Do\u0287ruk Ka\u00e7ar","year":"2014","unstructured":"Do\u0287ruk Ka\u00e7ar S, \u00d6zu\u0287uz P, Ba\u0287cio\u0287lu E, Co\u015fkun K\u015e, Polat S, Karaca \u015e. Is a poor Dermatology Life Quality Index score a sign of stigmatization in patients with vitiligo? Turk Clin Dermatol. 2014;24(2):45\u201350.","journal-title":"Turk Clin Dermatol."},{"issue":"8","key":"631_CR75","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/1346-8138.12553","volume":"41","author":"G Erfan","year":"2014","unstructured":"Erfan G, Albayrak Y, Yanik ME, Oksuz O, Tasolar K, Topcu B, et al. Distinct temperament and character profiles in first onset vitiligo but not in alopecia areata. J Dermatol. 2014;41(8):709\u201315.","journal-title":"J Dermatol"},{"issue":"2","key":"631_CR76","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12529-017-9677-9","volume":"25","author":"N Essa","year":"2018","unstructured":"Essa N, Awad S, Nashaat M. Validation of an Egyptian Arabic version of Skindex-16 and quality of life measurement in Egyptian patients with skin disease. Int J Behav Med. 2018;25(2):243\u201351.","journal-title":"Int J Behav Med"},{"issue":"2","key":"631_CR77","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/bjd.13839","volume":"173","author":"K Ezzedine","year":"2015","unstructured":"Ezzedine K, Grimes PE, Meurant JM, Seneschal J, Leaute-Labreze C, Ballanger F, et al. Living with vitiligo: results from a national survey indicate differences between skin phototypes. Br J Dermatol. 2015;173(2):607\u20139.","journal-title":"Br J Dermatol"},{"issue":"1","key":"631_CR78","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jdds.2015.09.001","volume":"20","author":"MI Fatani","year":"2016","unstructured":"Fatani MI, Aldhahri RM, Al Otaibi HO, Kalo BB, Khalifa MA. Acknowledging popular misconceptions about vitiligo in western Saudi Arabia. J Dermatol Dermatol Surg. 2016;20(1):27\u201331.","journal-title":"J Dermatol Dermatol Surg."},{"issue":"11","key":"631_CR79","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/j.1365-4632.2004.02059.x","volume":"43","author":"A Firooz","year":"2004","unstructured":"Firooz A, Bouzari N, Fallah N, Ghazisaidi B, Firoozabadi MR, Dowlati Y. What patients with vitiligo believe about their condition. Int J Dermatol. 2004;43(11):811\u20134.","journal-title":"Int J Dermatol"},{"issue":"3","key":"631_CR80","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1001\/jamadermatol.2016.4670","volume":"153","author":"S Florez-Pollack","year":"2017","unstructured":"Florez-Pollack S, Jia G, Zapata L Jr, Rodgers C, Hernandez K, Hynan LS, et al. Association of quality of life and location of lesions in patients with vitiligo. JAMA Dermatol. 2017;153(3):341\u20132.","journal-title":"JAMA Dermatol"},{"issue":"45","key":"631_CR81","doi-asserted-by":"publisher","first-page":"168","DOI":"10.51910\/ijhdr.v12i45.638","volume":"12","author":"S Ganguly","year":"2013","unstructured":"Ganguly S, Saha S, Koley M, Mondal R. Homeopathic treatment of vitiligo: an open observational pilot study. Int J High Dilution Res. 2013;12(45):168\u201377.","journal-title":"Int J High Dilution Res."},{"issue":"3","key":"631_CR82","doi-asserted-by":"publisher","first-page":"e22359","DOI":"10.17795\/semj22359","volume":"15","author":"R Ghaderi","year":"2014","unstructured":"Ghaderi R, Saadatjoo A. Evaluating of life quality in Iranian patients with vitiligo using generic and special questionnaires. Shiraz E Med J. 2014;15(3):e22359.","journal-title":"Shiraz E Med J."},{"issue":"7","key":"631_CR83","first-page":"511","volume":"50","author":"M Ghajarzadeh","year":"2012","unstructured":"Ghajarzadeh M, Ghiasi M, Kheirkhah S. Associations between skin diseases and quality of life: a comparison of psoriasis, vitiligo, and alopecia areata. Acta Med Iran. 2012;50(7):511\u20135.","journal-title":"Acta Med Iran"},{"issue":"3\u20134","key":"631_CR84","first-page":"139","volume":"16","author":"\u00d6 G\u00fcler","year":"2009","unstructured":"G\u00fcler \u00d6, Karaca \u015e, A\u015fik AH, Yal\u00e7in C. Psychosocial symptoms in patients with psoriasis, vitiligo, and neurodermatitis. Neurol Psychiatry Brain Res. 2009;16(3\u20134):139\u201344.","journal-title":"Neurol Psychiatry Brain Res"},{"issue":"3","key":"631_CR85","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3906\/sag-1812-84","volume":"49","author":"A Gurpinar","year":"2019","unstructured":"Gurpinar A, Dogan Gunaydin S, Kilic C, Karaduman A. Association of serum cortisol and dehydroepiandrosterone sulfate (DHEAS) levels with psychological stress in patients with vitiligo. Turk J Med Sci. 2019;49(3):832\u20137.","journal-title":"Turk J Med Sci."},{"issue":"66","key":"631_CR86","first-page":"128","volume":"16","author":"F Handjani","year":"2013","unstructured":"Handjani F, Kalafi A. Impact of dermatological diseases on family members of the patients using Family Dermatology Life Quality Index: a preliminary study in Iran. Iran J Dermatol. 2013;16(66):128\u201331.","journal-title":"Iran J Dermatol."},{"key":"631_CR87","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jpsychores.2018.10.011","volume":"115","author":"AM Hassanin","year":"2018","unstructured":"Hassanin AM, Ismail NN, El Guindi A, Sowailam HA. The emotional burden of chronic skin disease dominates physical factors among women, adversely affecting quality of life and sexual function. J Psychosom Res. 2018;115:53\u20137.","journal-title":"J Psychosom Res"},{"key":"631_CR88","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12955-016-0490-y","volume":"14","author":"K Hedayat","year":"2016","unstructured":"Hedayat K, Karbakhsh M, Ghiasi M, Goodarzi A, Fakour Y, Akbari Z, et al. Quality of life in patients with vitiligo: a cross-sectional study based on Vitiligo Quality of Life index (VitiQoL). Health Qual Life Outcomes. 2016;14:86.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"631_CR89","first-page":"83","volume":"147","author":"V Ingordo","year":"2012","unstructured":"Ingordo V, Cazzaniga S, Gentile C, Iannazzone SS, Cusano F, Naldi L. Dermatology Life Quality Index score in vitiligo patients: a pilot study among young Italian males. G Ital Dermatol Venereol. 2012;147(1):83\u201390.","journal-title":"G Ital Dermatol Venereol"},{"issue":"3","key":"631_CR90","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000363407","volume":"229","author":"V Ingordo","year":"2014","unstructured":"Ingordo V, Cazzaniga S, Medri M, Raone B, Digiuseppe MD, Musumeci ML, et al. To what extent is quality of life impaired in vitiligo? A multicenter study on Italian patients using the Dermatology Life Quality Index. Dermatology. 2014;229(3):240\u20137.","journal-title":"Dermatology"},{"issue":"2","key":"631_CR91","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.dsi.2017.10.002","volume":"36","author":"P Juntongjin","year":"2018","unstructured":"Juntongjin P, Rachawong C, Nuallaong W. Knowledge and attitudes towards vitiligo in the general population: a survey based on the simulation video of a real situation. Dermatol Sin. 2018;36(2):75\u20138.","journal-title":"Dermatol Sin"},{"issue":"4","key":"631_CR92","doi-asserted-by":"publisher","first-page":"446","DOI":"10.2340\/00015555-1520","volume":"93","author":"M Karelson","year":"2013","unstructured":"Karelson M, Silm H, Kingo K. Quality of life and emotional state in vitiligo in an Estonian sample: comparison with psoriasis and healthy controls. Acta Derm Venereol. 2013;93(4):446\u201350.","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"631_CR93","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/08870449908407325","volume":"14","author":"G Kent","year":"1999","unstructured":"Kent G. Correlates of perceived stigma in vitiligo. Psychol Health. 1999;14(2):241\u201351.","journal-title":"Psychol Health"},{"issue":"2","key":"631_CR94","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/713690187","volume":"5","author":"G Kent","year":"2000","unstructured":"Kent G. Understanding the experiences of people with disfigurements: an integration of four models of social and psychological functioning. Psychol Health Med. 2000;5(2):117\u201329.","journal-title":"Psychol Health Med"},{"issue":"6","key":"631_CR95","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0190-9622(96)90112-7","volume":"35","author":"G Kent","year":"1996","unstructured":"Kent G, Al\u2019Abadie M. Psychologic effects of vitiligo: a critical incident analysis. J Am Acad Dermatol. 1996;35(6):895\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"631_CR96","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1365-2230.1996.tb00116.x","volume":"21","author":"G Kent","year":"1996","unstructured":"Kent G, Al-Abadie M. Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers. Clin Exp Dermatol. 1996;21(5):330\u20133.","journal-title":"Clin Exp Dermatol"},{"issue":"12","key":"631_CR97","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1111\/1346-8138.12276","volume":"40","author":"DY Kim","year":"2013","unstructured":"Kim DY, Lee J, Oh SH, Hann SK, Shin YJ. Impact of genital involvement on the sexual lives of vitiligo patients. J Dermatol. 2013;40(12):1065\u20137.","journal-title":"J Dermatol"},{"issue":"6","key":"631_CR98","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1346-8138.2009.00646.x","volume":"36","author":"DY Kim","year":"2009","unstructured":"Kim DY, Lee JW, Whang SH, Park YK, Hann SK, Shin YJ. Quality of life for Korean patients with vitiligo: Skindex-29 and its correlation with clinical profiles. J Dermatol. 2009;36(6):317\u201322.","journal-title":"J Dermatol"},{"key":"631_CR99","doi-asserted-by":"crossref","unstructured":"Kostopoulou P, Jouary T, Quintard B, Ezzedine K, Marques S, Boutchnei S, et al. Objective vs. subjective factors in the psychological impact of vitiligo: the experience from a French referral centre. Br J Dermatol. 2009;161(1):128\u201333.","DOI":"10.1111\/j.1365-2133.2009.09077.x"},{"issue":"2","key":"631_CR100","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4103\/idoj.IDOJ_14_18","volume":"10","author":"RS Kota","year":"2019","unstructured":"Kota RS, Vora RV, Varma JR, Kota SK, Patel TM, Ganjiwale J. Study on assessment of quality of life and depression in patients of vitiligo. Indian Dermatol Online J. 2019;10(2):153\u20137.","journal-title":"Indian Dermatol Online J"},{"issue":"1","key":"631_CR101","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1365-4632.2012.05656.x","volume":"53","author":"C Kruger","year":"2014","unstructured":"Kruger C, Panske A, Schallreuter KU. Disease-related behavioral patterns and experiences affect quality of life in children and adolescents with vitiligo. Int J Dermatol. 2014;53(1):43\u201350.","journal-title":"Int J Dermatol"},{"issue":"5","key":"631_CR102","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2340\/00015555-1981","volume":"95","author":"C Kruger","year":"2015","unstructured":"Kruger C, Schallreuter KU. Stigmatisation, avoidance behaviour and difficulties in coping are common among adult patients with vitiligo. Acta Derm Venereol. 2015;95(5):553\u20138.","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"631_CR103","first-page":"70","volume":"28","author":"C Kr\u00fcger","year":"2018","unstructured":"Kr\u00fcger C, Schallreuter KU. Increased levels of anxious-depressive mood in parents of children with vitiligo. Eur J Pediatr Dermatol. 2018;28(2):70\u20138.","journal-title":"Eur J Pediatr Dermatol"},{"issue":"2","key":"631_CR104","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2340\/00015555-1037","volume":"91","author":"C Kruger","year":"2011","unstructured":"Kruger C, Smythe JW, Spencer JD, Hasse S, Panske A, Chiuchiarelli G, et al. Significant immediate and long-term improvement in quality of life and disease coping in patients with vitiligo after group climatotherapy at the Dead Sea. Acta Derm Venereol. 2011;91(2):152\u20139.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"631_CR105","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/j.1365-2133.2008.08788.x","volume":"159","author":"MW Linthorst Homan","year":"2008","unstructured":"Linthorst Homan MW, de Korte J, Grootenhuis MA, Bos JD, Sprangers MA, van der Veen JP. Impact of childhood vitiligo on adult life. Br J Dermatol. 2008;159(4):915\u201320.","journal-title":"Br J Dermatol"},{"issue":"8","key":"631_CR106","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1001\/archderm.144.8.1062","volume":"144","author":"MW Linthorst Homan","year":"2008","unstructured":"Linthorst Homan MW, Sprangers MA, de Korte J, Bos JD, van der Veen JP. Characteristics of patients with universal vitiligo and health-related quality of life. Arch Dermatol. 2008;144(8):1062\u20134.","journal-title":"Arch Dermatol"},{"issue":"3","key":"631_CR107","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jaad.2009.03.022","volume":"61","author":"MW Linthorst Homan","year":"2009","unstructured":"Linthorst Homan MW, Spuls PI, de Korte J, Bos JD, Sprangers MA, van der Veen JP. The burden of vitiligo: patient characteristics associated with quality of life. J Am Acad Dermatol. 2009;61(3):411\u201320.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"631_CR108","first-page":"138","volume":"21","author":"Z Maghami","year":"2018","unstructured":"Maghami Z, Sepaskhah M, Sarani EM, Bagheri Z, Maghami M. Alexithymia in vitiligo patients: a case-control study. Iran J Dermatol. 2018;21(4):138\u201341.","journal-title":"Iran J Dermatol."},{"issue":"7","key":"631_CR109","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1468-3083.2006.02106.x","volume":"21","author":"L Manolache","year":"2007","unstructured":"Manolache L, Benea V. Stress in patients with alopecia areata and vitiligo. J Eur Acad Dermatol Venereol. 2007;21(7):921\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"631_CR110","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1590\/S0365-05962012000300002","volume":"87","author":"AP Manzoni","year":"2012","unstructured":"Manzoni AP, Pereira RL, Townsend RZ, Weber MB, Nagatomi AR, Cestari TF. Assessment of the quality of life of pediatric patients with the major chronic childhood skin diseases. An Bras Dermatol. 2012;87(3):361\u20138.","journal-title":"An Bras Dermatol"},{"issue":"6","key":"631_CR111","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1590\/abd1806-4841.20131915","volume":"88","author":"AP Manzoni","year":"2013","unstructured":"Manzoni AP, Weber MB, Nagatomi AR, Pereira RL, Townsend RZ, Cestari TF. Assessing depression and anxiety in the caregivers of pediatric patients with chronic skin disorders. An Bras Dermatol. 2013;88(6):894\u20139.","journal-title":"An Bras Dermatol"},{"issue":"5","key":"631_CR112","doi-asserted-by":"publisher","first-page":"592","DOI":"10.4103\/0378-6323.69097","volume":"76","author":"V Mashayekhi","year":"2010","unstructured":"Mashayekhi V, Javidi Z, Kiafar B, Manteghi AA, Saadatian V, Esmaeili HA, et al. Quality of life in patients with vitiligo: a descriptive study on 83 patients attending a PUVA therapy unit in Imam Reza Hospital, Mashad. Indian J Dermatol Venereol Leprol. 2010;76(5):592.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"8","key":"631_CR113","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1346-8138.2001.tb00004.x","volume":"28","author":"SK Mattoo","year":"2001","unstructured":"Mattoo SK, Handa S, Kaur I, Gupta N, Malhotra R. Psychiatric morbidity in vitiligo and psoriasis: a comparative study from India. J Dermatol. 2001;28(8):424\u201332.","journal-title":"J Dermatol"},{"issue":"6","key":"631_CR114","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1046\/j.1468-3083.2002.00590.x","volume":"16","author":"SK Mattoo","year":"2002","unstructured":"Mattoo SK, Handa S, Kaur I, Gupta N, Malhotra R. Psychiatric morbidity in vitiligo: prevalence and correlates in India. J Eur Acad Dermatol Venereol. 2002;16(6):573\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"631_CR115","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ad.2017.03.007","volume":"108","author":"MA Morales-Sanchez","year":"2017","unstructured":"Morales-Sanchez MA, Vargas-Salinas M, Peralta-Pedrero ML, Olguin-Garcia MG, Jurado-Santa Cruz F. Impact of vitiligo on quality of life. Actas Dermosifiliogr. 2017;108(7):637\u201342.","journal-title":"Actas Dermosifiliogr"},{"issue":"7","key":"631_CR116","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1468-3083.2011.04171.x","volume":"26","author":"S Moretti","year":"2012","unstructured":"Moretti S, Arunachalam M, Colucci R, Pallanti S, Kline JA, Berti S, et al. Autoimmune markers in vitiligo patients appear correlated with obsession and phobia. J Eur Acad Dermatol Venereol. 2012;26(7):861\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"631_CR117","first-page":"165","volume":"18","author":"O Mouzas","year":"2008","unstructured":"Mouzas O, Angelopoulos N, Papaliagka M, Tsogas P. Increased frequency of self-reported parasomnias in patients suffering from vitiligo. Eur J Dermatol. 2008;18(2):165\u20138.","journal-title":"Eur J Dermatol"},{"issue":"2","key":"631_CR118","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000182253","volume":"218","author":"T Nijsten","year":"2009","unstructured":"Nijsten T, Sampogna F, Abeni D. Categorization of Skindex-29 scores using mixture analysis. Dermatology. 2009;218(2):151\u20134.","journal-title":"Dermatology"},{"issue":"4","key":"631_CR119","doi-asserted-by":"publisher","first-page":"454","DOI":"10.5021\/ad.2013.25.4.454","volume":"25","author":"S Noh","year":"2013","unstructured":"Noh S, Kim M, Park CO, Hann SK, Oh SH. Comparison of the psychological impacts of asymptomatic and symptomatic cutaneous diseases: vitiligo and atopic dermatitis. Ann Dermatol. 2013;25(4):454\u201361.","journal-title":"Ann Dermatol"},{"issue":"2","key":"631_CR120","first-page":"55","volume":"14","author":"SM Noor","year":"2004","unstructured":"Noor SM, Khurshid K, Mahmood T, Haroon TS. Quality of life in vitiligo patients. J Pakistan Assoc Dermatol. 2004;14(2):55\u20138.","journal-title":"J Pakistan Assoc Dermatol."},{"key":"631_CR121","first-page":"1","volume":"2018","author":"\u00d6 \u00d6nen","year":"2018","unstructured":"\u00d6nen \u00d6, Kundak S, \u00d6zek Erkuran H, Kutlu A, \u00c7akaloz B. Quality of life, depression, and anxiety in Turkish children with vitiligo and their parents. Psychiat Clin Psych. 2018;2018:1\u201310.","journal-title":"Psychiat Clin Psych."},{"issue":"4","key":"631_CR122","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000084751","volume":"210","author":"K Ongenae","year":"2005","unstructured":"Ongenae K, Dierckxsens L, Brochez L, van Geel N, Naeyaert JM. Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage. Dermatology. 2005;210(4):279\u201385.","journal-title":"Dermatology"},{"issue":"6","key":"631_CR123","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1111\/j.1365-2133.2005.06456.x","volume":"152","author":"K Ongenae","year":"2005","unstructured":"Ongenae K, Van Geel N, De Schepper S, Naeyaert JM. Effect of vitiligo on self-reported health-related quality of life. Br J Dermatol. 2005;152(6):1165\u201372.","journal-title":"Br J Dermatol"},{"issue":"4","key":"631_CR124","first-page":"284","volume":"12","author":"AM Osman","year":"2009","unstructured":"Osman AM, Elkordufani Y, Abdullah MA. The psychological impact of vitiligo in adult Sudanese patients. Afr J Psychiatry (Johannesbg). 2009;12(4):284\u20136.","journal-title":"Afr J Psychiatry (Johannesbg)."},{"issue":"Pt 3","key":"631_CR125","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1348\/000711299160077","volume":"72","author":"L Papadopoulos","year":"1999","unstructured":"Papadopoulos L, Bor R, Legg C. Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy. Br J Med Psychol. 1999;72(Pt 3):385\u201396.","journal-title":"Br J Med Psychol"},{"issue":"4","key":"631_CR126","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/1354850021000015249","volume":"7","author":"L Papadopoulos","year":"2002","unstructured":"Papadopoulos L, Bor R, Walker C, Flaxman P, Legg C. Different shades of meaning: illness beliefs among vitiligo sufferers. Psychol Health Med. 2002;7(4):425\u201333.","journal-title":"Psychol Health Med"},{"issue":"4","key":"631_CR127","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000083091","volume":"5","author":"L Papadopoulos","year":"2004","unstructured":"Papadopoulos L, Walker C, Anthis L. Living with vitiligo: a controlled investigation into the effects of group cognitive-behavioural and person-centred therapies. Dermatol Psychosom. 2004;5(4):172\u20137.","journal-title":"Dermatol Psychosom"},{"issue":"1","key":"631_CR128","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/jdv.15255","volume":"33","author":"KR Patel","year":"2019","unstructured":"Patel KR, Singam V, Rastogi S, Lee HH, Silverberg NB, Silverberg JI. Association of vitiligo with hospitalization for mental health disorders in US adults. J Eur Acad Dermatol Venereol. 2019;33(1):191\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"631_CR129","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000069731","volume":"72","author":"A Picardi","year":"2003","unstructured":"Picardi A, Pasquini P, Cattaruzza MS, Gaetano P, Melchi CF, Baliva G, et al. Stressful life events, social support, attachment security and alexithymia in vitiligo: a case-control study. Psychother Psychosom. 2003;72(3):150\u20138.","journal-title":"Psychother Psychosom"},{"issue":"3","key":"631_CR130","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4103\/0378-6323.79699","volume":"77","author":"R Pichaimuthu","year":"2011","unstructured":"Pichaimuthu R, Ramaswamy P, Bikash K, Joseph R. A measurement of the stigma among vitiligo and psoriasis patients in India. Indian J Dermatol Venereol Leprol. 2011;77(3):300\u20136.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"6","key":"631_CR131","first-page":"493","volume":"39","author":"J Porter","year":"1987","unstructured":"Porter J, Beuf AH, Lerner A, Nordlund J. Response to cosmetic disfigurement: patients with vitiligo. Cutis. 1987;39(6):493\u20134.","journal-title":"Cutis"},{"issue":"1","key":"631_CR132","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0163-8343(79)90081-1","volume":"1","author":"J Porter","year":"1979","unstructured":"Porter J, Beuf AH, Nordlund JJ, Lerner AB. Psychological reaction to chronic skin disorders: a study of patients with vitiligo. Gen Hosp Psychiatry. 1979;1(1):73\u20137.","journal-title":"Gen Hosp Psychiatry"},{"issue":"2","key":"631_CR133","doi-asserted-by":"publisher","first-page":"192","DOI":"10.2307\/2137152","volume":"32","author":"JR Porter","year":"1991","unstructured":"Porter JR, Beuf AH. Racial variation in reaction to physical stigma: a study of degree of disturbance by vitiligo among black and white patients. J Health Soc Behav. 1991;32(2):192\u2013204.","journal-title":"J Health Soc Behav"},{"issue":"2 Pt 1","key":"631_CR134","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0190-9622(86)70160-6","volume":"15","author":"JR Porter","year":"1986","unstructured":"Porter JR, Beuf AH, Lerner A, Nordlund J. Psychosocial effect of vitiligo: a comparison of vitiligo patients with \u201cnormal\u201d control subjects, with psoriasis patients, and with patients with other pigmentary disorders. J Am Acad Dermatol. 1986;15(2 Pt 1):220\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"2 Pt 1","key":"631_CR135","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0190-9622(90)70028-G","volume":"22","author":"JR Porter","year":"1990","unstructured":"Porter JR, Beuf AH, Lerner AB, Nordlund JJ. The effect of vitiligo on sexual relationships. J Am Acad Dermatol. 1990;22(2 Pt 1):221\u20132.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"631_CR136","doi-asserted-by":"publisher","first-page":"703","DOI":"10.4103\/0378-6323.116743","volume":"79","author":"R Premkumar","year":"2013","unstructured":"Premkumar R, Kar B, Rajan P, Richard J. Major precipitating factors for stigma among stigmatized vitiligo and psoriasis patients with brown-black skin shades. Indian J Dermatol Venereol Leprol. 2013;79(5):703\u20135.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"631_CR137","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ajp.2017.04.018","volume":"29","author":"S Raikhy","year":"2017","unstructured":"Raikhy S, Gautam S, Kanodia S. Pattern and prevalence of psychiatric disorders among patients attending dermatology OPD. Asian J Psychiatr. 2017;29:85\u20138.","journal-title":"Asian J Psychiatr"},{"issue":"3","key":"631_CR138","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4103\/0253-7176.135385","volume":"36","author":"P Ramakrishna","year":"2014","unstructured":"Ramakrishna P, Rajni T. Psychiatric morbidity and quality of life in vitiligo patients. Indian J Psychol Med. 2014;36(3):302\u20133.","journal-title":"Indian J Psychol Med"},{"issue":"2","key":"631_CR139","first-page":"196","volume":"29","author":"F Saeedeh","year":"2019","unstructured":"Saeedeh F, Hossein S, Saman M, Maryam K, Rezvan A, Mahin A, et al. Evaluation of quality of life in parents of the patients with vitiligo by Persian version of the Family Dermatology Life Quality Index (FDLQI) in Kerman. J Pakistan Assoc Dermatol. 2019;29(2):196\u2013202.","journal-title":"J Pakistan Assoc Dermatol."},{"issue":"3","key":"631_CR140","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s40257-016-0172-x","volume":"17","author":"A Salman","year":"2016","unstructured":"Salman A, Kurt E, Topcuoglu V, Demircay Z. Social anxiety and quality of life in vitiligo and acne patients with facial involvement: a cross-sectional controlled study. Am J Clin Dermatol. 2016;17(3):305\u201311.","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"631_CR141","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000246657","volume":"190","author":"BA Salzer","year":"1995","unstructured":"Salzer BA, Schallreuter KU. Investigation of the personality structure in patients with vitiligo and a possible association with impaired catecholamine metabolism. Dermatology. 1995;190(2):109\u201315.","journal-title":"Dermatology"},{"issue":"2","key":"631_CR142","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1365-2133.2008.08678.x","volume":"159","author":"F Sampogna","year":"2008","unstructured":"Sampogna F, Raskovic D, Guerra L, Pedicelli C, Tabolli S, Leoni L, et al. Identification of categories at risk for high quality of life impairment in patients with vitiligo. Br J Dermatol. 2008;159(2):351\u20139.","journal-title":"Br J Dermatol"},{"issue":"2","key":"631_CR143","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4103\/0019-5154.152508","volume":"60","author":"LN Sangma","year":"2015","unstructured":"Sangma LN, Nath J, Bhagabati D. Quality of life and psychological morbidity in vitiligo patients: a study in a teaching hospital from north-East India. Indian J Dermatol. 2015;60(2):142\u20136.","journal-title":"Indian J Dermatol"},{"issue":"3","key":"631_CR144","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1080\/0092623X.2015.1010678","volume":"42","author":"D Sarhan","year":"2016","unstructured":"Sarhan D, Mohammed GF, Gomaa AH, Eyada MM. Female genital dialogues: female genital self-image, sexual dysfunction, and quality of life in patients with vitiligo with and without genital affection. J Sex Marital Ther. 2016;42(3):267\u201376.","journal-title":"J Sex Marital Ther"},{"issue":"4","key":"631_CR145","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4103\/ijd.IJD_142_18","volume":"63","author":"S Sarkar","year":"2018","unstructured":"Sarkar S, Sarkar T, Sarkar A, Das S. Vitiligo and psychiatric morbidity: a profile from a vitiligo clinic of a rural-based tertiary care center of Eastern India. Indian J Dermatol. 2018;63(4):281\u20134.","journal-title":"Indian J Dermatol"},{"key":"631_CR146","doi-asserted-by":"publisher","first-page":"6879412","DOI":"10.1155\/2019\/6879412","volume":"2019","author":"NS Sawant","year":"2019","unstructured":"Sawant NS, Vanjari NA, Khopkar U. Gender differences in depression, coping, stigma, and quality of life in patients of vitiligo. Dermatol Res Pract. 2019;2019:6879412.","journal-title":"Dermatol Res Pract"},{"issue":"4","key":"631_CR147","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1468-3083.2006.01897.x","volume":"21","author":"G Schmid-Ott","year":"2007","unstructured":"Schmid-Ott G, Kunsebeck HW, Jecht E, Shimshoni R, Lazaroff I, Schallmayer S, et al. Stigmatization experience, coping and sense of coherence in vitiligo patients. J Eur Acad Dermatol Venereol. 2007;21(4):456\u201361.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"631_CR148","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/bjd.12990","volume":"171","author":"R Shah","year":"2014","unstructured":"Shah R, Hunt J, Webb TL, Thompson AR. Starting to develop self-help for social anxiety associated with vitiligo: using clinical significance to measure the potential effectiveness of enhanced psychological self-help. Br J Dermatol. 2014;171(2):332\u20137.","journal-title":"Br J Dermatol"},{"issue":"7","key":"631_CR149","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/ced.12907","volume":"41","author":"OG Shaker","year":"2016","unstructured":"Shaker OG, Eltahlawi SM, Tawfic SO, Eltawdy AM, Bedair NI. Corticotropin-releasing hormone (CRH) and CRH receptor 1 gene expression in vitiligo. Clin Exp Dermatol. 2016;41(7):734\u201340.","journal-title":"Clin Exp Dermatol"},{"issue":"8","key":"631_CR150","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1346-8138.2001.tb00003.x","volume":"28","author":"N Sharma","year":"2001","unstructured":"Sharma N, Koranne RV, Singh RK. Psychiatric morbidity in psoriasis and vitiligo: a comparative study. J Dermatol. 2001;28(8):419\u201323.","journal-title":"J Dermatol"},{"issue":"2","key":"631_CR151","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1001\/jamadermatol.2013.927","volume":"149","author":"JI Silverberg","year":"2013","unstructured":"Silverberg JI, Silverberg NB. Association between vitiligo extent and distribution and quality-of-life impairment. JAMA Dermatol. 2013;149(2):159\u201364.","journal-title":"JAMA Dermatol"},{"issue":"3","key":"631_CR152","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/pde.12226","volume":"31","author":"JI Silverberg","year":"2014","unstructured":"Silverberg JI, Silverberg NB. Quality of life impairment in children and adolescents with vitiligo. Pediatr Dermatol. 2014;31(3):309\u201318.","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"631_CR153","first-page":"255","volume":"95","author":"JI Silverberg","year":"2015","unstructured":"Silverberg JI, Silverberg NB. Vitiligo disease triggers: psychological stressors preceding the onset of disease. Cutis. 2015;95(5):255\u201362.","journal-title":"Cutis"},{"issue":"1","key":"631_CR154","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/01.EWX.0000503397.22746.bd","volume":"14","author":"F Sorour","year":"2017","unstructured":"Sorour F, Abdelmoaty A, Bahary MH, El Birqdar B. Psychiatric disorders associated with some chronic dermatologic diseases among a group of Egyptian dermatology outpatient clinic attendants. J Egypt Womens Dermatol Soc. 2017;14(1):31\u20136.","journal-title":"J Egypt Womens Dermatol Soc."},{"issue":"1","key":"631_CR155","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/00926230600998482","volume":"33","author":"M Sukan","year":"2007","unstructured":"Sukan M, Maner F. The problems in sexual functions of vitiligo and chronic urticaria patients. J Sex Marital Ther. 2007;33(1):55\u201364.","journal-title":"J Sex Marital Ther"},{"issue":"1","key":"631_CR156","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1473-2165.2010.00479.x","volume":"9","author":"M Tanioka","year":"2010","unstructured":"Tanioka M, Yamamoto Y, Kato M, Miyachi Y. Camouflage for patients with vitiligo vulgaris improved their quality of life. J Cosmet Dermatol. 2010;9(1):72\u20135.","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"631_CR157","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1468-3083.2004.01124.x","volume":"19","author":"M Tjioe","year":"2005","unstructured":"Tjioe M, Otero ME, van de Kerkhof PC, Gerritsen MJ. Quality of life in vitiligo patients after treatment with long-term narrowband ultraviolet B phototherapy. J Eur Acad Dermatol Venereol. 2005;19(1):56\u201360.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"631_CR158","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1590\/abd1806-4841.20165060","volume":"91","author":"IO Topal","year":"2016","unstructured":"Topal IO, Duman H, Goncu OE, Durmuscan M, Gungor S, Ulkumen PK. Knowledge, beliefs, and perceptions of Turkish vitiligo patients regarding their condition. An Bras Dermatol. 2016;91(6):770\u20135.","journal-title":"An Bras Dermatol"},{"key":"631_CR159","first-page":"70","volume":"243","author":"N Tsintsadze","year":"2015","unstructured":"Tsintsadze N, Beridze L, Tsintsadze N, Krichun Y, Tsivadze N, Tsintsadze M. Psychosomatic aspects in patients with dermatologic diseases. Georgian Med News. 2015;243:70\u20135.","journal-title":"Georgian Med News"},{"issue":"5","key":"631_CR160","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.jaad.2018.11.047","volume":"80","author":"IA Vallerand","year":"2019","unstructured":"Vallerand IA, Lewinson RT, Parsons LM, Hardin J, Haber RM, Lowerison MW, et al. Vitiligo and major depressive disorder: a bidirectional population-based cohort study. J Am Acad Dermatol. 2019;80(5):1371\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"631_CR161","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1468-3083.2010.03808.x","volume":"25","author":"KY Wang","year":"2011","unstructured":"Wang KY, Wang KH, Zhang ZP. Health-related quality of life and marital quality of vitiligo patients in China. J Eur Acad Dermatol Venereol. 2011;25(4):429\u201335.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"631_CR162","first-page":"57","volume":"25","author":"ST Xu","year":"2017","unstructured":"Xu ST, Oh EH, Kim JE, Ko JY, Ro YS. Comparative study of quality of life between psoriasis, vitiligo and autoimmune bullous disease. Hong Kong J Dermatol Venereol. 2017;25(2):57\u201364.","journal-title":"Hong Kong J Dermatol Venereol."},{"issue":"5","key":"631_CR163","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1016\/j.jaad.2010.05.031","volume":"64","author":"Y Yamamoto","year":"2011","unstructured":"Yamamoto Y, Tanioka M, Hayashino Y, Mishina H, Kato M, Fukuhara S, et al. Application of a two-question screening instrument to detect depressive symptoms in patients with vitiligo: a pilot study. J Am Acad Dermatol. 2011;64(5):e69-70.","journal-title":"J Am Acad Dermatol"},{"key":"631_CR164","first-page":"2361","volume":"10","author":"ME Yanik","year":"2014","unstructured":"Yanik ME, Erfan G, Albayrak Y, Aydin M, Kulac M, Kuloglu M. Reduced serum brain-derived neurotrophic factor in patients with first onset vitiligo. Neuropsychiatr Dis Treat. 2014;10:2361\u20137.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"4","key":"631_CR165","first-page":"344","volume":"16","author":"S Zabetian","year":"2017","unstructured":"Zabetian S, Jacobson G, Lim HW, Eide MJ, Huggins RH. Quality of life in a vitiligo support group. J Drugs Dermatol. 2017;16(4):344\u201350.","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"631_CR166","first-page":"4","volume":"21","author":"S Zandi","year":"2011","unstructured":"Zandi S, Farajzadeh S, Saberi N. Effect of vitiligo on self reported quality of life in southern part of Iran. J Pakistan Assoc Dermatol. 2011;21(1):4\u20139.","journal-title":"J Pakistan Assoc Dermatol."},{"issue":"6","key":"631_CR167","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1046\/j.1365-2230.1998.00384.x","volume":"23","author":"L Papadopoulos","year":"1998","unstructured":"Papadopoulos L, Bor R, Legg C, Hawk JL. Impact of life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology. Clin Exp Dermatol. 1998;23(6):243\u20138.","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"631_CR168","doi-asserted-by":"publisher","first-page":"308","DOI":"10.4103\/0378-6323.175925","volume":"82","author":"A Jha","year":"2016","unstructured":"Jha A, Mehta M, Khaitan BK, Sharma VK, Ramam M. Cognitive behavior therapy for psychosocial stress in vitiligo. Indian J Dermatol Venereol Leprol. 2016;82(3):308\u201310.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"631_CR169","doi-asserted-by":"crossref","unstructured":"Thompson AR, Clarke SA, Newell RJ, Gawkrodger DJ, Appearance Research Collaboration. Vitiligo linked to stigmatization in British South Asian women: a qualitative study of the experiences of living with vitiligo. Br J Dermatol. 2010;163(3):481\u20136.","DOI":"10.1111\/j.1365-2133.2010.09828.x"},{"issue":"Pt 2","key":"631_CR170","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1348\/135910702169457","volume":"7","author":"AR Thompson","year":"2002","unstructured":"Thompson AR, Kent G, Smith JA. Living with vitiligo: dealing with difference. Br J Health Psychol. 2002;7(Pt 2):213\u201325.","journal-title":"Br J Health Psychol"},{"issue":"5","key":"631_CR171","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1590\/S0365-05962012000500027","volume":"87","author":"MA Penha","year":"2012","unstructured":"Penha MA, Santos PM, Miot HA. Dimensioning the fear of dermatologic diseases. An Bras Dermatol. 2012;87(5):796\u20139.","journal-title":"An Bras Dermatol"},{"issue":"5","key":"631_CR172","doi-asserted-by":"publisher","first-page":"679","DOI":"10.4103\/0378-6323.116737","volume":"79","author":"P Pahwa","year":"2013","unstructured":"Pahwa P, Mehta M, Khaitan BK, Sharma VK, Ramam M. The psychosocial impact of vitiligo in Indian patients. Indian J Dermatol Venereol Leprol. 2013;79(5):679\u201385.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"631_CR173","first-page":"300","volume":"18","author":"A Ray","year":"2011","unstructured":"Ray A, Pal MK, Ghosh M, Sanyal D. Psychodermatological disorders: an assessment of psychiatric morbidity. Int Med J. 2011;18(4):300\u20134.","journal-title":"Int Med J."},{"issue":"3","key":"631_CR174","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ad.2016.11.008","volume":"108","author":"G Sanclemente","year":"2017","unstructured":"Sanclemente G, Burgos C, Nova J, Hernandez F, Gonzalez C, Reyes MI, et al. The impact of skin diseases on quality of life: a multicenter study. Actas Dermosifiliogr. 2017;108(3):244\u201352.","journal-title":"Actas Dermosifiliogr"},{"issue":"4","key":"631_CR175","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/01.psy.0000132869.96872.b2","volume":"66","author":"F Sampogna","year":"2004","unstructured":"Sampogna F, Picardi A, Chren MM, Melchi CF, Pasquini P, Masini C, et al. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med. 2004;66(4):620\u20134.","journal-title":"Psychosom Med"},{"issue":"4","key":"631_CR176","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/0163-8343(84)90024-0","volume":"6","author":"A Hill-Beuf","year":"1984","unstructured":"Hill-Beuf A, Porter JD. Children coping with impaired appearance: social and psychologic influences. Gen Hosp Psychiatry. 1984;6(4):294\u2013301.","journal-title":"Gen Hosp Psychiatry"},{"issue":"6","key":"631_CR177","doi-asserted-by":"publisher","first-page":"635","DOI":"10.4103\/0019-5154.169140","volume":"60","author":"SK Kosaraju","year":"2015","unstructured":"Kosaraju SK, Reddy KS, Vadlamani N, Sandhya L, Kalasapati L, Maganti S, et al. Psychological morbidity among dermatological patients in a rural setting. Indian J Dermatol. 2015;60(6):635.","journal-title":"Indian J Dermatol"},{"issue":"10244","key":"631_CR178","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0140-6736(20)30609-7","volume":"396","author":"D Rosmarin","year":"2020","unstructured":"Rosmarin D, Pandya AG, Lebwohl M, Grimes P, Hamzavi I, Gottlieb AB, et al. Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial. Lancet. 2020;396(10244):110\u201320.","journal-title":"Lancet"},{"issue":"3","key":"631_CR179","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/jocd.13648","volume":"20","author":"S Kanokrungsee","year":"2021","unstructured":"Kanokrungsee S, Pruettivorawongse D, Rajatanavin N. Clinical outcomes of topical bimatoprost for nonsegmental facial vitiligo: a preliminary study. J Cosmet Dermatol. 2021;20(3):812\u20138.","journal-title":"J Cosmet Dermatol"},{"key":"631_CR180","first-page":"1","volume":"2020","author":"HJ Ju","year":"2020","unstructured":"Ju HJ, Kim SH, Lee JH, Kim GM, Bae JM. Efficacy and safety of tretinoin 0.05% cream to prevent hyperpigmentation during narrowband UV-B phototherapy in patients with facial vitiligo: a randomized clinical trial. J Dermatolog Treat. 2020;2020:1\u20134.","journal-title":"J Dermatolog Treat"},{"issue":"7","key":"631_CR181","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.jid.2020.12.028","volume":"141","author":"J Seneschal","year":"2021","unstructured":"Seneschal J, Duplaine A, Maillard H, Passeron T, Andreu N, Lassalle R, et al. Efficacy and safety of tacrolimus 0.1% for the treatment of facial vitiligo: a multicenter randomized, double-blinded, vehicle-controlled study. J Invest Dermatol. 2021;141(7):1728\u201334.","journal-title":"J Invest Dermatol."},{"issue":"3","key":"631_CR182","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210\u20136.","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"631_CR183","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/j.1365-2133.2008.08881.x","volume":"159","author":"DJ Gawkrodger","year":"2008","unstructured":"Gawkrodger DJ, Ormerod AD, Shaw L, Mauri-Sole I, Whitton ME, Watts MJ, et al. Guideline for the diagnosis and management of vitiligo. Br J Dermatol. 2008;159(5):1051\u201376.","journal-title":"Br J Dermatol"},{"issue":"1","key":"631_CR184","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.jaad.2012.01.038","volume":"69","author":"E Lilly","year":"2013","unstructured":"Lilly E, Lu PD, Borovicka JH, Victorson D, Kwasny MJ, West DP, et al. Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL). J Am Acad Dermatol. 2013;69(1):e11\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"631_CR185","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/ijd.13198","volume":"55","author":"AA Amer","year":"2016","unstructured":"Amer AA, Gao XH. Quality of life in patients with vitiligo: an analysis of the Dermatology Life Quality Index outcome over the past two decades. Int J Dermatol. 2016;55(6):608\u201314.","journal-title":"Int J Dermatol"},{"issue":"5","key":"631_CR186","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jaad.2019.02.008","volume":"81","author":"K Ezzedine","year":"2019","unstructured":"Ezzedine K, Ahmed M, Tovar-Garza A, Hajj C, Whitton M, Pandya A, et al. Cross-cultural validation of a short-form of the Vitiligo Impact Patient scale (VIPs). J Am Acad Dermatol. 2019;81(5):1107\u201314.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"631_CR187","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1016\/j.jid.2016.08.021","volume":"136","author":"AM Drucker","year":"2016","unstructured":"Drucker AM, Fleming P, Chan AW. Research techniques made simple: assessing risk of bias in systematic reviews. J Invest Dermatol. 2016;136(11):e109\u201314.","journal-title":"J Invest Dermatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-021-00631-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-021-00631-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-021-00631-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T03:21:34Z","timestamp":1699500094000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-021-00631-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,23]]},"references-count":187,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["631"],"URL":"https:\/\/doi.org\/10.1007\/s40257-021-00631-6","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,23]]},"assertion":[{"value":"27 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was funded by Incyte Corporation, Wilmington, DE, USA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"KE is a consultant for AbbVie, Incyte Corporation, La Roche-Posay, Pfizer, Pierre Fabre, Sanofi, and Viela Bio. VE has nothing to disclose. HJ and FIK were employees and shareholders of Incyte Corporation when the study was conducted. KB and DS are employees and shareholders of Incyte Corporation. AGP has served as an investigator for Aclaris Therapeutics, Immune Tolerance Network, Incyte Corporation, and Pfizer; a consultant for Arcutis, Avita, Chromaderm, Immune Tolerance Network, Incyte Corporation, Pfizer, Viela Bio, and Villaris; and a board member who also holds stock options for Clarify Medical and Tara Medical.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest\/Competing Interests"}},{"value":"Because data were collected from published articles, no ethical approval was required for the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"All data were collected from published articles available in the public domain.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"KE, VE, HJ, KB, FIK, DS, and AGP contributed to the study design, including formulation of the search strategy, had access to extracted data, and contributed to data interpretation. KE, VE, HJ, KB, FIK, DS, and AGP were involved in drafting the manuscript. KE, VE, HJ, KB, FIK, DS, and AGP approved the final version for submission and agree to be accountable for all aspects of the work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}},{"value":"Data in this article were previously presented, in part, at the European Academy of Dermatology and Venereology 2020 Virtual Congress (29\u201331 October, 2020) and the Vitiligo International Symposium 2020 Virtual Conference (5\u20136 December, 2020).","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Prior Presentations"}}]}}